Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23Andme Holding Co. (NQ: ME )

0.5172 +0.1610 (+45.20%)
Streaming Delayed Price Updated: 10:47 AM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 23Andme Holding Co.

< Previous 1 2 3 4 5 6 Next >
Walgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts
Walgreens layoffs are in the news Thursday after the pharmacy chain announced plans to cut jobs in Chicago while reducing employees' hours. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Looking Into 23andMe Holding's Recent Short Interest
Via Benzinga
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023. 
Via The Motley Fool
Looking Into 23andMe Holding's Recent Short Interest
Via Benzinga
Is 23andMe Stock a Smart Buy Right Now?
It's having trouble getting its core business model to work. 
Via The Motley Fool
Recap: 23andMe Holding Q3 Earnings
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock
Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside. 
Via The Motley Fool
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown... 
Via Benzinga
Former YouTube CEO's Teenaged Son Found Dead At UC Berkeley
The 19-year-old's grandmother, Esther Wojcicki, known as the "Godmother of Silicon Valley," says his death was likely a drug overdose. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
A Preview Of 23andMe Holding's Earnings
Via Benzinga
Crude Oil Gains 3%; Kellanova Posts Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 30 points on Thursday. The Dow traded down 0.01% to 38,675.29 while the NASDAQ rose 0.19% to 15,787.09. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. 
Via Benzinga
Dow Tumbles Over 100 Points; US Initial Jobless Claims Fall Last Week
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.29% to 38,565.98 while the NASDAQ rose 0.26% to 15,796.91. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Is Invitae (NVTA) Stock Down 75% Today?
Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock. 
Via InvestorPlace
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Troubled Biotech Company's Investigational Cancer Drug Gets Greenlighted By FDA
This development marks a significant milestone for 23andMe, a company that has been in the spotlight for security breaches in the past. 
Via Benzinga
23andMe Faces Class Action Lawsuit Over Alleged Privacy Breach Targeting Chinese And Ashkenazi Jewish Customers
23andMe faces a class-action lawsuit for a privacy breach affecting 7 million customers, particularly Chinese and Ashkenazi Jewish customers. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them
Not all of my investments have been winners. Here are three that went badly and the important lessons I learned from them. 
Via The Motley Fool
23andMe Reveals Hackers Accessed 'Significant Number' Of DNA Records
23andMe confirmed that hackers accessed around 14,000 customer accounts and an undisclosed number of files containing users' ancestry data. 
Via Benzinga
Topics Hacking
Exposures Information Security
The 3 Best Digital Health Stocks for Personalized Medicine
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. 
Via InvestorPlace
The Top 7 Stocks to Own During a Downturn
Investors tend to get jittery in October but these seven stocks to own during a downturn will protect your portfolio 
Via InvestorPlace
23andMe Under Siege: Hacker Reportedly Steals Millions Of Profiles In Genetic Data Heist
An unidentified hacker reportedly claims to have stolen personal genetic data from millions of 23andMe Holding Co. (NASDAQ: ME) customer accounts, sparking concerns over privacy and security. 
Via Benzinga
Topics Hacking
Exposures Information Security
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 5 Health Care Stocks That May Explode In Q3
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.